457 related articles for article (PubMed ID: 20562702)
1. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis.
Rice TW; Wheeler AP; Bernard GR; Vincent JL; Angus DC; Aikawa N; Demeyer I; Sainati S; Amlot N; Cao C; Ii M; Matsuda H; Mouri K; Cohen J
Crit Care Med; 2010 Aug; 38(8):1685-94. PubMed ID: 20562702
[TBL] [Abstract][Full Text] [Related]
2. Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis.
Tidswell M; Tillis W; Larosa SP; Lynn M; Wittek AE; Kao R; Wheeler J; Gogate J; Opal SM;
Crit Care Med; 2010 Jan; 38(1):72-83. PubMed ID: 19661804
[TBL] [Abstract][Full Text] [Related]
3. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial.
Boerma EC; Koopmans M; Konijn A; Kaiferova K; Bakker AJ; van Roon EN; Buter H; Bruins N; Egbers PH; Gerritsen RT; Koetsier PM; Kingma WP; Kuiper MA; Ince C
Crit Care Med; 2010 Jan; 38(1):93-100. PubMed ID: 19730258
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial.
Dellinger RP; Tomayko JF; Angus DC; Opal S; Cupo MA; McDermott S; Ducher A; Calandra T; Cohen J;
Crit Care Med; 2009 Nov; 37(11):2929-38. PubMed ID: 19770753
[TBL] [Abstract][Full Text] [Related]
5. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J;
Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
[TBL] [Abstract][Full Text] [Related]
6. Early administration of high-dose antithrombin in severe sepsis: single center results from the KyberSept-trial.
Eid A; Wiedermann CJ; Kinasewitz GT
Anesth Analg; 2008 Nov; 107(5):1633-8. PubMed ID: 18931224
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial.
Opal S; Laterre PF; Abraham E; Francois B; Wittebole X; Lowry S; Dhainaut JF; Warren B; Dugernier T; Lopez A; Sanchez M; Demeyer I; Jauregui L; Lorente JA; McGee W; Reinhart K; Kljucar S; Souza S; Pribble J;
Crit Care Med; 2004 Feb; 32(2):332-41. PubMed ID: 14758145
[TBL] [Abstract][Full Text] [Related]
9. Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
Jacobs S; Price Evans DA; Tariq M; Al Omar NF
Crit Care Med; 2003 Jul; 31(7):1938-46. PubMed ID: 12847386
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest.
Mentzelopoulos SD; Zakynthinos SG; Tzoufi M; Katsios N; Papastylianou A; Gkisioti S; Stathopoulos A; Kollintza A; Stamataki E; Roussos C
Arch Intern Med; 2009 Jan; 169(1):15-24. PubMed ID: 19139319
[TBL] [Abstract][Full Text] [Related]
11. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock.
Mikkelsen ME; Miltiades AN; Gaieski DF; Goyal M; Fuchs BD; Shah CV; Bellamy SL; Christie JD
Crit Care Med; 2009 May; 37(5):1670-7. PubMed ID: 19325467
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock.
Stephens DP; Thomas JH; Higgins A; Bailey M; Anstey NM; Currie BJ; Cheng AC
Crit Care Med; 2008 Feb; 36(2):448-54. PubMed ID: 18216600
[TBL] [Abstract][Full Text] [Related]
13. Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study).
Jaimes F; De La Rosa G; Morales C; Fortich F; Arango C; Aguirre D; Muñoz A
Crit Care Med; 2009 Apr; 37(4):1185-96. PubMed ID: 19242322
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
James ND; Caty A; Borre M; Zonnenberg BA; Beuzeboc P; Morris T; Phung D; Dawson NA
Eur Urol; 2009 May; 55(5):1112-23. PubMed ID: 19042080
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
[TBL] [Abstract][Full Text] [Related]
17. Stress doses of hydrocortisone in high-risk patients undergoing cardiac surgery: effects on interleukin-6 to interleukin-10 ratio and early outcome.
Weis F; Beiras-Fernandez A; Schelling G; Briegel J; Lang P; Hauer D; Kreth S; Kaufmann I; Lamm P; Kilger E
Crit Care Med; 2009 May; 37(5):1685-90. PubMed ID: 19325469
[TBL] [Abstract][Full Text] [Related]
18. A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome.
Vincent JL; Brase R; Santman F; Suter PM; McLuckie A; Dhainaut JF; Park Y; Karmel J
Intensive Care Med; 2001 Oct; 27(10):1578-83. PubMed ID: 11685297
[TBL] [Abstract][Full Text] [Related]
19. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock.
Pontes-Arruda A; Aragão AM; Albuquerque JD
Crit Care Med; 2006 Sep; 34(9):2325-33. PubMed ID: 16850002
[TBL] [Abstract][Full Text] [Related]
20. Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis.
Albertson TE; Panacek EA; MacArthur RD; Johnson SB; Benjamin E; Matuschak GM; Zaloga G; Maki D; Silverstein J; Tobias JK; Haenftling K; Black G; Cowens JW;
Crit Care Med; 2003 Feb; 31(2):419-27. PubMed ID: 12576946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]